Long-term protection against malaria after experimental sporozoite inoculation: an open-label follow-up study.
about
Immune mechanisms in malaria: new insights in vaccine developmentSystems immunology of human malariaImmunoregulation in human malaria: the challenge of understanding asymptomatic infectionMalaria vaccines: identifying Plasmodium falciparum liver-stage targetsApplication of radiation technology in vaccines developmentPaths to a malaria vaccine illuminated by parasite genomicsDiscovery of Novel Plasmodium falciparum Pre-Erythrocytic Antigens for Vaccine DevelopmentProtective immunity to liver-stage malariaThe March Toward Malaria VaccinesExternal quality assurance of malaria nucleic acid testing for clinical trials and eradication surveillanceSporozoite immunization of human volunteers under mefloquine prophylaxis is safe, immunogenic and protective: a double-blind randomized controlled clinical trialComparison of clinical and parasitological data from controlled human malaria infection trialsA hybrid multistage protein vaccine induces protective immunity against murine malariaInactivation of a Plasmodium apicoplast protein attenuates formation of liver merozoitesSeasonal vaccination against malaria: a potential use for an imperfect malaria vaccine.Phenotypic characterization of Plasmodium berghei responsive CD8+ T cells after immunization with live sporozoites under chloroquine coverMalaria vaccine research and development: the role of the WHO MALVAC committeeMalaria immunity in man and mosquito: insights into unsolved mysteries of a deadly infectious disease.Artesunate versus chloroquine infection-treatment-vaccination defines stage-specific immune responses associated with prolonged sterile protection against both pre-erythrocytic and erythrocytic Plasmodium yoelii infection.Sporozoite immunization of human volunteers under chemoprophylaxis induces functional antibodies against pre-erythrocytic stages of Plasmodium falciparum.Antigen export during liver infection of the malaria parasite augments protective immunityAntibodies against PfEMP1, RIFIN, MSP3 and GLURP are acquired during controlled Plasmodium falciparum malaria infections in naïve volunteers.Long term protection after immunization with P. berghei sporozoites correlates with sustained IFNγ responses of hepatic CD8+ memory T cells.Cytotoxic markers associate with protection against malaria in human volunteers immunized with Plasmodium falciparum sporozoites.Vaccines against malaria-still a long way to go.Memory B-cell and antibody responses induced by Plasmodium falciparum sporozoite immunization.DNA prime/Adenovirus boost malaria vaccine encoding P. falciparum CSP and AMA1 induces sterile protection associated with cell-mediated immunity.A genetically attenuated malaria vaccine candidate based on P. falciparum b9/slarp gene-deficient sporozoitesOptimising Controlled Human Malaria Infection Studies Using Cryopreserved P. falciparum Parasites Administered by Needle and Syringe.Successful human infection with P. falciparum using three aseptic Anopheles stephensi mosquitoes: a new model for controlled human malaria infection.The case for a rational genome-based vaccine against malaria.Chemotherapeutics challenges in developing effective treatments for the endemic malariasA Meta-Analysis of Experimental Studies of Attenuated Schistosoma mansoni Vaccines in the Mouse Model.CD8+ T cells from a novel T cell receptor transgenic mouse induce liver-stage immunity that can be boosted by blood-stage infection in rodent malaria.A cluster-randomized trial of mass drug administration with a gametocytocidal drug combination to interrupt malaria transmission in a low endemic area in Tanzania.Chloroquine neither eliminates liver stage parasites nor delays their development in a murine Chemoprophylaxis Vaccination model.Drugs for malaria: something old, something new, something borrowed.Heterologous Protection against Malaria after Immunization with Plasmodium falciparum Sporozoites.Longevity and composition of cellular immune responses following experimental Plasmodium falciparum malaria infection in humansMechanisms of stage-transcending protection following immunization of mice with late liver stage-arresting genetically attenuated malaria parasites.
P2860
Q21032484-8029A526-4426-4EC4-A241-D635634AB397Q21032488-BE64D48F-29FE-425A-B660-D7D7E7D54796Q26775212-C0005B0C-D4C4-4B59-B3D5-765657B21520Q26781372-66C404E0-7E80-457B-91F2-F6F9E6A6868CQ26798165-AABB93D2-2D3B-4AC0-A5C7-1A91610EC58AQ26853267-3DC2C748-C4B3-490F-B2D5-72490F89F089Q27972709-C4838432-7BD4-42B3-ADAA-58063B0D160EQ28068626-5B0E277C-4128-4C2E-B18A-A2B891B170B2Q28084325-6221CD4C-858C-417C-93CB-410E52B68032Q28538917-B724CFCC-E66A-4136-820C-4C3554A896B1Q28544964-043904DB-7A2F-4863-9CD0-4B54534F5054Q28728616-BDC4BAB7-3EA1-4EC8-8179-EF6A09B0CA64Q28730779-A03716D9-AE78-47F8-B01D-1223A50D989EQ30043892-CFB470C1-D1CD-4F08-A2AB-DE21908FCC1BQ30234589-C2A10C17-6489-4BDC-A2CC-DAB051197F9AQ33558847-B4DDED83-E7DF-4D59-9647-D3C9174B661EQ33611463-6A12E015-3A87-43EA-B488-73F7089774A3Q33821137-0200A1EA-EF06-4063-85E1-C2F9A685C871Q33927133-B3D2CF94-78D4-4985-8EDA-918DA381078CQ33960093-FB203B1D-9D7C-43AA-B6C3-86313037D57DQ34026260-D1A77348-081B-4F5C-B2D1-44527339C8A1Q34103586-EE4BA87C-B36F-48B0-A791-2C1B2FE7BCCCQ34260189-C54011E9-3347-45B1-B8B8-66087F530644Q34399831-5C6D5D07-27A4-43E6-AB2D-C9FC4FE3A808Q34556687-EB1947D6-5D3E-4975-B66F-0D8764183D46Q34563555-885A3640-CCE1-4348-856F-807A1BC3E518Q34606356-B4E45E8A-C9CE-4C99-8728-C23DDAF4D0CAQ34753532-471E232D-9CF8-458B-9538-50549CB9FD90Q34792326-F4E8D1DC-CF3B-4641-8DC4-823AD42A95A7Q34852105-756C50FC-1231-43C5-9DC7-B8096F6C0C81Q34999392-2F77D652-BC0F-4B58-A245-5F579EE005E7Q35095657-349CE071-C9B1-4EC3-AD3B-20F6452BEA12Q35128551-D10D4C75-F4CE-4F78-AB34-B9AD0DDF5B57Q35172830-0B904454-8CE7-457D-89F9-DE002B8DA43DQ35203887-E7070ABF-81B1-47ED-B558-27EFCF59C1BAQ35336088-4EE8B99B-5A3D-434B-82DD-BC37B8926312Q35507886-20CE6246-F839-4D21-8B87-ACFD81EA76C0Q35560599-35C23DAE-7292-404F-8BAF-9958E69D3B29Q35586865-E51FBB89-7C3D-450C-908C-66A3949954C8Q35606514-750633C9-C5FB-40E7-8CF6-E4A8F010C8BC
P2860
Long-term protection against malaria after experimental sporozoite inoculation: an open-label follow-up study.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Long-term protection against m ...... an open-label follow-up study.
@en
type
label
Long-term protection against m ...... an open-label follow-up study.
@en
prefLabel
Long-term protection against m ...... an open-label follow-up study.
@en
P2093
P1433
P1476
Long-term protection against m ...... an open-label follow-up study.
@en
P2093
Adrian J F Luty
André J A M van der Ven
Anne C Teirlinck
Cornelus C Hermsen
GeertJan van Gemert
Jorien Wiersma
Karina Teelen
Krystelle Nganou Makamdop
Matthew B B McCall
Meta Roestenberg
P304
P356
10.1016/S0140-6736(11)60360-7
P407
P577
2011-04-22T00:00:00Z